Although patients with chronic kidney disease (CKD) typically have reduced responsiveness to clopidogrel, a Korean registry study suggests doubling the loading dose prior to primary percutaneous ...
Evidence suggests that platelet reactivity can increase the risk of thrombosis and ischemic events after coronary stenting. The dose at which clopidogrel is most effective and whether the addition of ...
The critical role of adequate antiplatelet therapy after stent deployment for the prevention of stent thrombosis has been well established in a series of randomized studies. Initially, the ...
September 26, 2011 (Rome, Italy) — The first prospective, randomized study to compare a 600-mg loading dose of clopidogrel with a 300-mg dose in patients with ST-elevation myocardial infarction (STEMI ...
ORLANDO, FL—Patients with coronary artery disease who need to switch from ticagrelor to clopidogrel after PCI should receive a loading dose of 600 mg clopidogrel between 12 and 24 hours following ...
Please provide your email address to receive an email when new articles are posted on . Patients with MI with nonobstructive coronary arteries, or MINOCA, have fewer recurrent events than those with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A reduction of infarct size and improvement of ...
In a recent randomized study, Gurbel and colleagues have examined the effect of clopidogrel dosing on the incidence of nonresponsiveness and high post-treatment platelet aggregation. In comparison ...
Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results